Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Thomas, J ^a   Thomas, C J ^a   Radcliffe, J ^a   Itsiopoulos, C ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; ARACHIDONIC ACID; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CHOLINESTERASE INHIBITOR; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HERBACEOUS AGENT; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; SATURATED FATTY ACID; SOMATOMEDIN; TAU PROTEIN; THIAMINE;

ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN FUNCTION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENCEPHALITIS; GENE EXPRESSION; GINKGO BILOBA; HISTOPATHOLOGY; HUMAN; NEUROFIBRILLARY TANGLE; PRIMARY PREVENTION; RISK FACTOR; WECHSLER INTELLIGENCE SCALE; AGING; DIET; DIET THERAPY; DIETARY SUPPLEMENT; METABOLISM; PATHOLOGY;

AGING; ALZHEIMER DISEASE; DIET; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84939780674     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/172801     Document Type: Article

References (100)

1. M. L. Daviglus, C. C. Bell, W. Berrettini et al., "National Institutes of Health state-of-The-science conference statement: preventing Alzheimer disease and cognitive decline," Annals of Internal Medicine, vol. 153, no. 3, pp. 176-181, 2010.
2. World Health Organization and Alzheimer's Disease International, Dementia: A Public Health Priority, 2012, http://www .who.int/mental health/publications/dementia report 2012/en/.
3. B. Shatenstein, M. J. Kergoat, and I. Reid, "Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls," Journal of the American Dietetic Association, vol. 107, no. 12, pp. 2091-2099, 2007.
4. Y. Gu, J.W. Nieves, Y. Stern, J. A. Luchsinger, and N. Scarmeas, "Food combination and alzheimer disease risk: a protective diet," Archives of Neurology, vol. 67, no. 6, pp. 699-706, 2010.
5. M. H. Laitinen, T. Ngandu, S. Rovio et al., "Fat intake at midlife and risk of dementia and Alzheimer's disease: a populationbased study," Dementia and Geriatric Cognitive Disorders, vol. 22, no. 1, pp. 99-107, 2006.
6. L. B. Lopez, D. Kritz-Silverstein, and E. Barrett-Connor, "HIgh dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the rancho bernardo study," Journal of Nutrition, Health and Aging, vol. 15, no. 1, pp. 25-31, 2011.
7. J. A. Luchsinger and R. Mayeux, "Dietary factors and Alzheimer's disease," The Lancet Neurology, vol. 3, no. 10, pp. 579-587, 2004.
8. N. Scarmeas, Y. Stern, M.-X. Tang, R. Mayeux, and J. A. Luchsinger, "Mediterranean diet and risk for Alzheimer's disease," Annals of Neurology, vol. 59, no. 6, pp. 912-921, 2006.
9. R. S. Opie, R. A. Ralston, and K. Z. Walker, "Adherence to a mediterranean-style diet can slow the rate of cognitive decline and decrease the risk of dementia: a systematic review," Nutrition and Dietetics, vol. 70, no. 3, pp. 206-217, 2013.
10. F. Sofi,F. Cesari, R. Abbate,G.F. Gensini, andA. Casini, "Adherence to mediterranean diet and health status: meta-Analysis," British Medical Journal, vol. 337, p. a1344, 2008.
11. J. L. Bayer-Carter, P. S. Green, T. J. Montine et al., "Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment," Archives of Neurology, vol. 68, no. 6, pp. 743-752, 2011.
12. M. Karczewska-Kupczewska, I. Kowalska, A. Nikołajuk et al., "Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fatmeal in young healthymale subjects," Diabetes Care, vol. 35, no. 2, pp. 358-362, 2012.
13. C. E. Ramsden, A. Ringel, A. E. Feldstein et al., "Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 87, no. 4-5, pp. 135-141, 2012.
14. C. E. Ramsden, K. R. Faurot, D. Zamora et al., "Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial," Pain, vol. 154, no. 11, pp. 2441-2451, 2013.
15. C.-C. Chiu, K.-P. Su, T.-C. Cheng et al., "The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 6, pp. 1538-1544, 2008.
16. S. Kotani, E. Sakaguchi, S. Warashina et al., "Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction," Neuroscience Research, vol. 56, no. 2, pp. 159-164, 2006.
17. L. K. Lee, S. Shahar, A.-V. Chin, and N. A. M. Yusoff, "Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial," Psychopharmacology, vol. 225, no. 3, pp. 605-612, 2013.
18. R. Cazzola, M. Rondanelli, M. Faliva, and B. Cestaro, "Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment," Experimental Gerontology, vol. 47, no. 12, pp. 974-978, 2012.
19. M. J. Mahmoudi,M. Hedayat, F. Sharifi et al., "Effect of lowdose ω-3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study," Journal of Diabetes & Metabolic Disorders, vol. 13, no. 1, article 34, 2014.
20. P. F. Boston, A. Bennett, D. F. Horrobin, and C. N. Bennett, "Ethyl-EPA in Alzheimer's disease-A pilot study," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 5, pp. 341-346, 2004.
21. Y. Freund-Levi, M. Eriksdotter-Jönhagen, T. Cederholm et al., "Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study -A randomized double-blind trial," Archives of Neurology, vol. 63, no. 10, pp. 1402-1408, 2006.
22. Y. Freund-Levi, H. Basun, T. Cederholm et al., "Omega-3 supplementation in mild to moderate Alzheimer's disease: Effects on neuropsychiatric symptoms," International Journal of Geriatric Psychiatry, vol. 23, no. 2, pp. 161-169, 2008.
23. J. F. Quinn, R. Raman, R. G. Thomas et al., "Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial," Journal of the American Medical Association, vol. 304, no. 17, pp. 1903-1911, 2010.
24. N. D. Barnard, A. I. Bush,, A. Ceccarelli et al., "Dietary and lifestyle guidelines for the prevention of Alzheimer's disease," Neurobiology of Aging, vol. 35, supplement 2, pp. S74-S78, 2014.
25. J.-Y. Han and S.-H. Han, "Primary prevention of Alzheimer's disease: is it an attainable goal?" Journal of Korean Medical Science, vol. 29, no. 7, pp. 886-892, 2014.
26. P. M. Kris-Etherton, J. A. Grieger, and T. D. Etherton, "Dietary reference intakes for DHA and EPA," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 81, no. 2-3, pp. 99-104, 2009.
27. B. C. Davis and P. M. Kris-Etherton, "Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications," The American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 640S-646S, 2003.
28. J. T. Brenna, N. Salem Jr., A. J. Sinclair, and S. C. Cunnane, " α-linolenic acid supplementation and conversion to n-3 longchain polyunsaturated fatty acids in humans," Prostaglandins Leukotrienes and Essential FattyAcids, vol. 80,no. 2-3, pp.85-91, 2009.
29. A. P. DeFilippis and L. S. Sperling, "Understanding omega-3's," American Heart Journal, vol. 151, no. 3, pp. 564-570, 2006.
30. C. M. Williams and G. Burdge, "Long-chain n-3 PUFA: plant v. marine sources," Proceedings of the Nutrition Society, vol. 65, no. 1, pp. 42-50, 2006.
31. C. Hetz and B. Mollereau, "Disturbance of endoplasmic reticulumproteostasis inneurodegenerativediseases," Nature Reviews Neuroscience, vol. 15, no. 4, pp. 233-249, 2014.
32. G. C. Brown and J. J. Neher, "Inflammatory neurodegeneration and mechanisms of microglial killing of neurons," Molecular Neurobiology, vol. 41, no. 2-3, pp. 242-247, 2010.
33. M. T. Heneka, J. J. Rodríguez, and A. Verkhratsky, "Neuroglia in neurodegeneration," Brain Research Reviews, vol. 63, no. 1-2, pp. 189-211, 2010.
34. K. Blennow, M. J. de Leon, and H. Zetterberg, "Alzheimer's disease," The Lancet, vol. 368, no. 9533, pp. 387-403, 2006.
35. D. H. Kim, S. H. Yeo, J.-M. Park et al., "Genetic markers for diagnosis and pathogenesis of Alzheimer's disease," Gene, vol. 545, no. 2, pp. 185-193, 2014.
36. M. A. Lynch and K. H. G. Mills, "Immunology meets neuroscience-opportunities for immune intervention in neurodegenerative diseases," Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 1-10, 2012.
37. M. T. Heneka,M. P. Kummer, and E. Latz, "Innate immune activation in neurodegenerative disease," Nature Reviews Immunology, vol. 14, no. 7, pp. 463-477, 2014.
38. F. Zipp and O. Aktas, "The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases," Trends in Neurosciences, vol. 29, no. 9, pp. 518-527, 2006.
39. P. J. Khandelwal, A.M. Herman, and C. E.-H. Moussa, "Inflammation in the early stages of neurodegenerative pathology," Journal of Neuroimmunology, vol. 238, no. 1-2, pp. 1-11, 2011.
40. E. Badoer, "Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction," The International Journal of Biochemistry & Cell Biology, vol. 42, no. 10, pp. 1580-1585, 2010.
41. C. K. Glass, K. Saijo, B. Winner,M.C. Marchetto, and F. H. Gage, "Mechanisms underlying inflammation in neurodegeneration," Cell, vol. 140, no. 6, pp. 918-934, 2010.
42. M. M. Esiri, "The interplay between inflammation and neurodegeneration in CNS disease," Journal of Neuroimmunology, vol. 184, no. 1-2, pp. 4-16, 2007.
43. S. Lehrer and P. H. Rheinstein, "Is Alzheimer's disease autoimmune inflammation of the brain that can be treated with nasal nonsteroidal anti-inflammatory drugs?" The American Journal of Alzheimer's Disease and Other Dementias, 2014.
44. J. Thomas, M. L. Garg, and D. W. Smith, "Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice," The Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1735-1740, 2013.
45. S. M. de la Monte, "Type 3 diabetes is sporadic Alzheimer's disease: mini-review," EuropeanNeuropsychopharmacology, vol. 24, no. 12, pp. 1954-1960, 2014.
46. L. D. Baker, D. J. Cross, S. Minoshima, D. Belongia, G. Stennis Watson, and S. Craft, "Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes," Archives of Neurology, vol. 68, no. 1, pp. 51-57, 2011.
47. S. M. de la Monte, L. Longato, M. Tong, and J. R. Wands, "Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-Alcoholic steatohepatitis," Current Opinion in Investigational Drugs, vol. 10, no. 10, pp. 1049-1060, 2009.
48. A. Ott, R. P. Stolk, F. van Harskamp, H. A. P. Pols, A. Hofman, and M. M. B. Breteler, "Diabetes mellitus and the risk of dementia: the Rotterdam Study," Neurology, vol. 53, no. 9, pp. 1937-1942, 1999.
49. T. Matsuzaki, K. Sasaki, Y. Tanizaki et al., "Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study," Neurology, vol. 75, no. 9, pp. 764-770, 2010.
50. L. Velayudhan, M. Poppe, N. Archer, P. Proitsi, R. G. Brown, and S. Lovestone, "Risk of developing dementia in people with diabetes and mild cognitive impairment," British Journal of Psychiatry, vol. 196, no. 1, pp. 36-40, 2010.
51. S. Gauthier, B. Reisberg, M. Zaudig et al., "Mild cognitive impairment," The Lancet, vol. 367, no. 9518, pp. 1262-1270, 2006.
52. ClinicalTrials.gov, Clinical Trials for Alzheimers Disease, http:// www.clinicaltrials.gov/ct2/results?term=alzheimer
53. J. R. Hecker and C. A. Snellgrove, "Pharmacological management of Alzheimer's disease," Journal of Pharmacy Practice and Research, vol. 33, no. 1, pp. 24-29, 2003.
54. V. Kotsirilos, L. Vitetta, and A. Sali, A Guide to Evidence-Based Integrative and Complementary Medicine, Elsevier, Chatswood, Australia, 2011.
55. D. W. Luchtman and C. Song, "Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies," Neuropharmacology, vol. 64, pp. 550-565, 2013.
56. N. G. Bazan and B. L. Scott, "Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses," Upsala Journal of Medical Sciences, Supplement, no. 48, pp. 97-107, 1990.
57. J. A. Luchsinger, J. M. Noble, and N. Scarmeas, "Diet and Alzheimer's disease," Current Neurology and Neuroscience Reports, vol. 7, no. 5, pp. 366-372, 2007.
58. C. Itsiopoulos, L. Brazionis, M. Kaimakamis et al., "Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study," Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 740-747, 2011.
59. Y. Yoshida, A. Yoshikawa, T. Kinumi et al., "Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers," Neurobiology of Aging, vol. 30, no. 2, pp. 174-185, 2009.
60. J. D. Moreira, L. Knorr, M. Ganzella et al., "Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations," Neurochemistry International, vol. 56, no. 6-7, pp. 753-759, 2010.
61. B. Koletzko, E. Larqué, andH. Demmelmair, "Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA)," Journal of Perinatal Medicine, vol. 35, supplement 1, pp. S5-S11, 2007.
62. N. G. Bazan, W. C. Gordon, and E. B. Rodriguez de Turco, "Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process," Advances in Experimental Medicine and Biology, vol. 318, pp. 295-306, 1992.
63. R. E. Martin and N. G. Bazan, "Changing fatty acid content of growth cone lipids prior to synaptogenesis," Journal of Neurochemistry, vol. 59, no. 1, pp. 318-325, 1992.
64. E. Larqué, S. Krauss-Etschmann, C. Campoy et al., "Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins," The American Journal of Clinical Nutrition, vol. 84, no. 4, pp. 853-861, 2006.
65. S. R. de Vriese, C. Matthys, S. de Henauw, G. de Backer, M. Dhont, and A. B. Christophe, "Maternal and umbilical fatty acid status in relation to maternal diet," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 6, pp. 389-396, 2002.
66. J. A. Dunstan, T. A. Mori, A. Barden et al., "Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy onmaternal and fetal erythrocyte fatty composition," European Journal of Clinical Nutrition, vol. 58, no. 3, pp. 429-437, 2004.
67. W. J. Lukiw and N. G. Bazan, "Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease: a review on the bioactivity of neuroprotectin D1 and apoptosis," Molecular Neurobiology, vol. 42, no. 1, pp. 10-16, 2010.
68. J. M. Bourre, "Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2. Macronutrients," Journal of Nutrition, Health and Aging, vol. 10, no. 5, pp. 386-399, 2006.
69. H.-M. Su, "Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance," Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 364-373, 2010.
70. M. Akbar, F. Calderon, Z. Wen, and H.-Y. Kim, "Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 10858-10863, 2005.
71. M. A. Crawford, I. Golfetto, K. Ghebremeskel et al., "The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants," Lipids, vol. 38, no. 4, pp. 303-315, 2003.
72. S. C. Dyall, G. J. Michael, and A. T. Michael-Titus, "Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats," Journal of Neuroscience Research, vol. 88, no. 10, pp. 2091-2102, 2010.
73. M. Plourde, M. Fortier, M. Vandal et al., "Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 301-308, 2007.
74. J. A. Conquer, M. C. Tierney, J. Zecevic, W. J. Bettger, and R. H. Fisher, "Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment," Lipids, vol. 35, no. 12, pp. 1305-1312, 2000.
75. R. S. Greiner, T. Moriguchi, A. Hutton, B. M. Slotnick, and N. Salem Jr., "Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks," Lipids, vol. 34,no. 1, supplement,pp. S239-S243, 1999.
76. N. G. Bazan, "Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease," Journal of Lipid Research, vol. 50, supplement, pp. S400-S405, 2009.
77. G. M. Cole and S. A. Frautschy, "DHA may prevent age-related dementia," Journal of Nutrition, vol. 140, no. 4, pp. 869-874, 2010.
78. M. Hashimoto, Y. Tanabe, Y. Fujii, R. Hagiwara, H. Yamasaki, and O. Shido, "Mechanism of improvement of spatial cognition with dietary docosahexaenoic acid," Nihon Yakurigaku Zasshi, vol. 120, no. 1, pp. 54P-56P, 2002.
79. A. Wu, Z. Ying, and F. Gomez-Pinilla, "Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition," Neuroscience, vol. 155, no. 3, pp. 751-759, 2008.
80. F. Calon, G. P. Lim, T. Morihara et al., "Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease," European Journal of Neuroscience, vol. 22, no. 3, pp. 617-626, 2005.
81. Y. Elgersma, J. D. Sweatt, and K. P. Giese, "Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition," Journal of Neuroscience, vol. 24, no. 39, pp. 8410-8415, 2004.
82. M. O. W. Grimm, J. Kuchenbecker, S. Grosgen et al., "Docosahexaenoic acid reduces amyloid β production via multiple pleiotropic mechanisms,"The Journal of Biological Chemistry, vol. 286, no. 16, pp. 14028-14039, 2011.
83. M. Nishikawa, S. Kimura, and N. Akaike, "Facilitatory effect of docosahexaenoic acid on N-methyl-D-Aspartate response in pyramidal neurones of rat cerebral cortex," The Journal of Physiology, vol. 475, no. 1, pp. 83-93, 1994.
84. J. S. Poling, J. W. Karanian, N. Salem Jr., and S. Vicini, "Timeand voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid," Molecular Pharmacology, vol. 47, no. 2, pp. 381-390, 1995.
85. L. A. Horrocks and A. A. Farooqui, "Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 70, no. 4, pp. 361-372, 2004.
86. D. B. Jump, "Dietary polyunsaturated fatty acids and regulation of gene transcription," CurrentOpinion in Lipidology, vol. 13,no. 2, pp. 155-164, 2002.
87. T. Farkas, K. Kitajka, E. Fodor et al., "Docosahexaenoic acidcontaining phospholipid molecular species in brains of vertebrates," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6362-6366, 2000.
88. K. Kitajka, L. G. Puskás, Á. Zvara et al., "The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2619-2624, 2002.
89. G. Barceló-Coblijn, K. Kitajka, L. G. Puskás et al., "Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1632, no. 1-3, pp. 72-79, 2003.
90. G. P. Lim, F. Calon, T. Morihara et al., "A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model," Journal of Neuroscience, vol. 25, no. 12, pp. 3032-3040, 2005.
91. J. S. Fernandes, M. A. Mori, R. Ekuni, R. M. W. Oliveira, and H. Milani, "Long-Termtreatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia," Nutrition Research, vol. 28, no. 11, pp. 798-808, 2008.
92. M. Pomponi and M. Pomponi, "DHA deficiency and Alzheimer's disease," Clinical Nutrition, vol. 27, no. 1, p. 170, 2008.
93. S. Delion, S. Chalon, D. Guilloteau, B. Lejeune, J.-C. Besnard, and G. Durand, "Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet," Journal of Lipid Research, vol. 38, no. 4, pp. 680-689, 1997.
94. D. Swanson, R. Block, and S. A. Mousa, "Omega-3 fatty acids EPA and DHA: health benefits throughout life," Advances in Nutrition, vol. 3, no. 1, pp. 1-7, 2012.
95. A. Cherubini, C. Andres-Lacueva, A. Martin et al., "Lowplasma N-3 fatty acids and dementia in older persons: the InCHIANTI study," Journals of Gerontology -Series A Biological Sciences and Medical Sciences, vol. 62, no. 10, pp. 1120-1126, 2007.
96. C.-C. Chiu, S. Frangou, C.-J. Chang et al., "Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression," American Journal of Clinical Nutrition, vol. 95, no. 2, pp. 420-427, 2012.
97. B. Heude, P. Ducimetière, and C. Berr, "Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA Study," The American Journal of Clinical Nutrition, vol. 77, no. 4, pp. 803-808, 2003.
98. A. M. Tully, H. M. Roche,R. Doyle et al., "Lowserumcholesteryl ester-docosahexaenoic acid levels inAlzheimer's disease: a casecontrol study," British Journal of Nutrition, vol. 89, no. 4, pp. 483-489, 2003.
99. F. Sofi, R. Abbate, G. F. Gensini, and A. Casini, "Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-Analysis," The American Journal of Clinical Nutrition, vol. 92, no. 5, pp. 1189-1196, 2010.
100. E. H. Martínez-Lapiscina, P. Clavero, E. Toledo et al., "Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial," Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 12, pp. 1318-1325, 2013.